NFE2L2 and familial pancreatic carcinoma: Persistent activation of Nrf2 results in tumorigenesis, in this way, the Nrf2 inhibitors can be used to inhibit the persistent Nrf2 activation induced by loss of autophagic function to prevent the progression of pancreatic cancer.